TRAWS PHARMA INC (TRAW) Stock Income Statement
NASDAQ:TRAW - Nasdaq - US68232V8845 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 227.00K | 226.00K | 226.00K | 226.00K | 226.00K | |||
| Operating Expenses | 25.13M | 25.14M | 20.52M | 19.85M | 16.72M | |||
| Research and Development | 13.44M | 12.85M | 11.43M | 11.41M | 7.30M | |||
| Selling, General, and Administrative Expenses | 11.69M | 12.29M | 9.09M | 8.45M | 9.43M | |||
| Operating Income | -24.90M | -24.91M | -20.30M | -19.63M | -16.50M | |||
| Interest Income/Expense | N/A | 510.00K | 1.39M | 0.00 | 321.00K | |||
| Other Income/Expense | 2.31M | -24.66M | -41.00K | 663.00K | 12.00K | |||
| Non Recurring Items | N/A | -117.46M | N/A | N/A | N/A | |||
| Income Before Taxes | -140.05M | -166.52M | -18.95M | -18.96M | -16.16M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -34.61M | -54.67M | -18.95M | -18.96M | -16.16M | |||
| EBITDA | -24.89M | -24.90M | -20.28M | -19.61M | -16.48M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -101.75 | -35.21 | -22.57 | -22.68 | -24.01 | |||
| Non GAAP EPS | N/A | N/A | -0.90 | -0.91 | -0.94 | |||
| Statistics | ||||||||
| Profit Margin | -15245.81% | -24192.04% | -8384.07% | -8391.15% | -7151.77% | |||
| Operating Profit Margin | -10969.60% | -11022.12% | -8981.42% | -8684.51% | -7299.12% | |||
All data in USD